Arbutus: IP Drama With High Stakes
Source: SeekingAlpha
2025-09-15 16:27:30 ET
Investment Thesis
Arbutus Biopharma, headquartered in Warminster, Pennsylvania, is a clinical-stage biopharmaceutical company . Its main focus is on expertise in liposomal drug delivery and RNA interference. Arbutus owns a broad and diverse patent portfolio covering various functional aspects of lipid nanoparticle (LNP) technology. LNP technology is mainly known as being used in mRNA-based COVID-19 vaccines made by Moderna and Pfizer/BioNTech . In addition, Arbutus is also developing drugs for chronic hepatitis B virus infection (HBV)....
Read the full article on Seeking Alpha
For further details see:
Arbutus: IP Drama With High Stakes
Pfizer Inc.
NASDAQ: PFE
PFE Trading
0.24% G/L:
$27.22 Last:
18,921,744 Volume:
$27.20 Open:
PFE Latest News
PFE Stock Data
$156,612,814,520
5,628,850,476
0.02%
1712
N/A
Pharmaceuticals
Healthcare
US
New York
